{
    "nct_id": "NCT06873815",
    "official_title": "A Single-Arm Prospective Trial of Fluorescein Mapping in Patients Undergoing Vulvectomy for Extramammary Paget's Disease",
    "inclusion_criteria": "* Age â‰¥18 years\n* Noninvasive or microinvasive EMPD with a contiguous visible clinical lesion\n* Newly diagnosed or recurrent lesion\n* Scheduled to undergo wide local excision or vulvectomy not requiring resection of the clitoris, urethra, or anus and with the surgeon's judgment that primary closure is possible (V-Y advancement flap closure is allowed)\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of allergic reaction to fluorescein sodium\n* Multifocal, noncontiguous clinical lesion\n* Current or previous invasive EMPD\n* History of invasive vulvar, vaginal, or anal cancer\n* Lesion in which resection of the clitoris, urethra, and/or anus is deemed to be necessary\n* Lesion in which a primary closure or V-Y advancement flap is believed not to be possible and a larger myocutaneous flap is needed for closure of the defect\n* History of radiation therapy to the vulva and/or anus",
    "miscellaneous_criteria": ""
}